Sana Ahuja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sana Ahuja has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Sufian Zaheer
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
58 shared publications - Adil Aziz Khan
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
24 shared publications - Charanjeet Ahluwalia
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
16 shared publications Charanjeet Ahluwalia
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
14 shared publicationsSunil Ranga
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
14 shared publicationsAdil Aziz Khan
Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
11 shared publications
Latest Publications
- 17 October 2026
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 24 (4) , 107
When Two Malignancies Collide: Synchronous Malignant Phyllodes Tumor and Triple-Negative Breast Carcinoma
- 17 October 2026
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 24 (4) , 107
When Two Malignancies Collide: Synchronous Malignant Phyllodes Tumor and Triple-Negative Breast Carcinoma
- 14 October 2026
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 24 (4) , 78
Tumor Budding, E-Cadherin Expression, and Tumor Infiltrating Lymphocytes in Endometrial Carcinoma
- 14 October 2026
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 24 (4) , 78
Tumor Budding, E-Cadherin Expression, and Tumor Infiltrating Lymphocytes in Endometrial Carcinoma
- Open Access
- 9 September 2026
- Published by Springer Nature in Surgical and Experimental Pathology
- Vol. 9 (1) , 50
Seeds of invasion in a field of immunity inside the tumor microenvironment: an H&E-based evaluation of stromal TIL density and tumor budding in colorectal carcinoma
Background: Colorectal carcinoma (CRC) is a major cause of cancer-related morbidity and mortality worldwide. Stromal tumor-infiltrating lymphocytes (TILs), an important component of the tumor microenvironment, have emerged as potential modulators of tumor behavior. Their relationship with tumor budding and other histopathological indicators of aggressiveness remains incompletely understood. The objectives of the study were to evaluate the association between stromal TIL density and clinicopathological parameters, including tumor budding and metastatic indicators, in colorectal carcinoma. Materials and methods: This retrospective study included 35 histologically confirmed cases of colorectal carcinoma. Resection specimens were examined on routine H&E-stained sections. Stromal TILs were assessed according to the International Immuno-Oncology Biomarker Working Group guidelines and categorized as low (< 50%) or high (≥ 50%) density, a threshold applied for descriptive dichotomization in this exploratory cohort in the absence of a cut-off specifically validated for colorectal carcinoma. Tumor budding was assessed at the invasive front according to International Tumor Budding Consensus Conference (ITBCC) 2016 criteria. Associations between TIL density and clinicopathological variables, including tumor grade, stage, nodal status, lymphovascular invasion (LVI), perineural invasion (PNI), depth of invasion, tumor side, and tumor budding, were analyzed using Fisher’s exact test. A p-value < 0.05 was considered statistically significant. Results: The mean patient age was 50.2 years. Most tumors were moderately differentiated adenocarcinomas and predominantly right-sided. Stromal TIL density was low (< 50%) in 22 cases (62.9%) and high (≥ 50%) in 13 cases (37.1%). High stromal TIL density showed significant associations with lower tumor grade, absence of lymphovascular invasion, absence of perineural invasion, and lower tumor budding on univariate analysis. Conclusion: In this small, single-institution cohort, high stromal TIL density was associated with less aggressive histopathological features, including lower tumor grade and reduced tumor budding, lymphovascular invasion and perineural invasion. H&E-based assessment of stromal TILs may represent a simple, reproducible morphological parameter warranting further validation as an adjunct marker of tumor aggressiveness in CRC, pending confirmation in larger, prospective, multi-institutional cohorts with outcome data.
- 9 September 2026
- Published by Springer Nature in Surgical and Experimental Pathology
- Vol. 9 (1) , 50
Open AccessSeeds of invasion in a field of immunity inside the tumor microenvironment: an H&E-based evaluation of stromal TIL density and tumor budding in colorectal carcinoma
Background: Colorectal carcinoma (CRC) is a major cause of cancer-related morbidity and mortality worldwide. Stromal tumor-infiltrating lymphocytes (TILs), an important component of the tumor microenvironment, have emerged as potential modulators of tumor behavior. Their relationship with tumor budding and other histopathological indicators of aggressiveness remains incompletely understood. The objectives of the study were to evaluate the association between stromal TIL density and clinicopathological parameters, including tumor budding and metastatic indicators, in colorectal carcinoma. Materials and methods: This retrospective study included 35 histologically confirmed cases of colorectal carcinoma. Resection specimens were examined on routine H&E-stained sections. Stromal TILs were assessed according to the International Immuno-Oncology Biomarker Working Group guidelines and categorized as low (< 50%) or high (≥ 50%) density, a threshold applied for descriptive dichotomization in this exploratory cohort in the absence of a cut-off specifically validated for colorectal carcinoma. Tumor budding was assessed at the invasive front according to International Tumor Budding Consensus Conference (ITBCC) 2016 criteria. Associations between TIL density and clinicopathological variables, including tumor grade, stage, nodal status, lymphovascular invasion (LVI), perineural invasion (PNI), depth of invasion, tumor side, and tumor budding, were analyzed using Fisher’s exact test. A p-value < 0.05 was considered statistically significant. Results: The mean patient age was 50.2 years. Most tumors were moderately differentiated adenocarcinomas and predominantly right-sided. Stromal TIL density was low (< 50%) in 22 cases (62.9%) and high (≥ 50%) in 13 cases (37.1%). High stromal TIL density showed significant associations with lower tumor grade, absence of lymphovascular invasion, absence of perineural invasion, and lower tumor budding on univariate analysis. Conclusion: In this small, single-institution cohort, high stromal TIL density was associated with less aggressive histopathological features, including lower tumor grade and reduced tumor budding, lymphovascular invasion and perineural invasion. H&E-based assessment of stromal TILs may represent a simple, reproducible morphological parameter warranting further validation as an adjunct marker of tumor aggressiveness in CRC, pending confirmation in larger, prospective, multi-institutional cohorts with outcome data.
- 3 April 2026
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 15 (4) , 238-246
Diagnostic accuracy of the WHO reporting system for lung fine-needle aspiration biopsies: a systematic review and meta-analysis
- 3 April 2026
- Published by Elsevier in Journal of the American Society of Cytopathology
- Vol. 15 (4) , 238-246
Diagnostic accuracy of the WHO reporting system for lung fine-needle aspiration biopsies: a systematic review and meta-analysis
- Open Access
- 17 March 2026
- Published by Charles University in Prague, Karolinum Press in Prague Medical Report
- Vol. 127 (1) , 15-20
Evaluation of Glasgow Microenvironment Score in Colorectal Carcinoma and Its Association with Prognostic Markers
Colorectal carcinoma (CRC) ranks among the most prevalent cancers worldwide, contributing significantly to cancer-related mortality. Despite advancements in understanding CRC’s pathophysiology, traditional staging systems like tumour, node, and metastasis (TNM) lack comprehensive prognostic indicators, particularly regarding tumour microenvironment and host-related factors. The Glasgow Microenvironment Score (GMS) integrates inflammatory cell infiltration and stromal percentage, offering a potentially more comprehensive prognostic tool. This study aims to evaluate GMS in CRC and its correlation with established clinicopathological prognostic markers and pathological tumour, node, and metastasis (pTNM) staging. A retrospective study involving 68 CRC patients who underwent curative surgery between January 2022 and March 2024. Haematoxylin and eosin-stained sections were assessed for inflammatory infiltration (Klintrup-Mäkinen score) and tumour stromal percentage, forming the GMS. Statistical analyses evaluated associations between GMS and clinicopathological markers, including lymphovascular invasion (LVI), perineural invasion (PNI), nodal status, and histological grading. The study found significant correlations between GMS and poor prognostic markers. High GMS was associated with increased LVI, PNI, and nodal involvement. GMS showed significant associations with LVI (p<0.0003), PNI (p<0.026), and nodal involvement (p<0.002). GMS serves as a robust prognostic indicator in CRC, correlating with key pathological features that influence patient outcomes. This scoring system could enhance traditional prognostic models, aiding in better stratification of CRC patients for therapeutic interventions.
- 17 March 2026
- Published by Charles University in Prague, Karolinum Press in Prague Medical Report
- Vol. 127 (1) , 15-20
Open AccessEvaluation of Glasgow Microenvironment Score in Colorectal Carcinoma and Its Association with Prognostic Markers
Colorectal carcinoma (CRC) ranks among the most prevalent cancers worldwide, contributing significantly to cancer-related mortality. Despite advancements in understanding CRC’s pathophysiology, traditional staging systems like tumour, node, and metastasis (TNM) lack comprehensive prognostic indicators, particularly regarding tumour microenvironment and host-related factors. The Glasgow Microenvironment Score (GMS) integrates inflammatory cell infiltration and stromal percentage, offering a potentially more comprehensive prognostic tool. This study aims to evaluate GMS in CRC and its correlation with established clinicopathological prognostic markers and pathological tumour, node, and metastasis (pTNM) staging. A retrospective study involving 68 CRC patients who underwent curative surgery between January 2022 and March 2024. Haematoxylin and eosin-stained sections were assessed for inflammatory infiltration (Klintrup-Mäkinen score) and tumour stromal percentage, forming the GMS. Statistical analyses evaluated associations between GMS and clinicopathological markers, including lymphovascular invasion (LVI), perineural invasion (PNI), nodal status, and histological grading. The study found significant correlations between GMS and poor prognostic markers. High GMS was associated with increased LVI, PNI, and nodal involvement. GMS showed significant associations with LVI (p<0.0003), PNI (p<0.026), and nodal involvement (p<0.002). GMS serves as a robust prognostic indicator in CRC, correlating with key pathological features that influence patient outcomes. This scoring system could enhance traditional prognostic models, aiding in better stratification of CRC patients for therapeutic interventions.
- Open Access
- 17 March 2026
- Published by Charles University in Prague, Karolinum Press in Prague Medical Report
- Vol. 127 (1) , 21-26
PD-L1 Expression in Gliomas: A Potential Immunotherapeutic Target in High-grade Tumours
Gliomas are the most common primary tumours of the central nervous system, with glioblastoma (grade 4 glioma) being the most malignant form. Despite standard therapy, patient survival remains poor. Immune checkpoint blockade targeting the PD-1/PD-L1 axis has shown promise in other cancers, but its role in gliomas remains under investigation. This study evaluates PD-L1 expression in gliomas and its correlation with tumour grade. A total of 50 histologically confirmed glioma cases were studied. Tumours were graded according to WHO 2021 CNS classification, and immunohistochemistry (IHC) was performed using antibodies for IDH, ATRX, TP53, Ki67, and PD-L1. PD-L1 expression was scored using an immunoreactivity scale, and its association with tumour grade was analysed using ordinal regression. A p-value < 0.05 was considered statistically significant. Among the 50 gliomas, the majority were astrocytoma, IDH-mutant (54%) followed by glioblastoma, IDH-wild type (26%). Most tumours were grade 4 (44%), grade 2 (34%), or grade 3 (18%). PD-L1 expression was detected exclusively in grade 4 tumours, with 6 of 22 (27.27%) cases showing positive expression. No expression was noted in grade 1–3 tumours. The association between PD-L1 expression and tumour grade was statistically significant (p=0.007). PD-L1 expression is limited to high-grade (grade 4) gliomas, suggesting a role in immune evasion. These findings support the potential utility of PD-L1 as a biomarker to identify glioma patients who may benefit from anti-PD-1/PD-L1 immunotherapy.
- 17 March 2026
- Published by Charles University in Prague, Karolinum Press in Prague Medical Report
- Vol. 127 (1) , 21-26
Open AccessPD-L1 Expression in Gliomas: A Potential Immunotherapeutic Target in High-grade Tumours
Gliomas are the most common primary tumours of the central nervous system, with glioblastoma (grade 4 glioma) being the most malignant form. Despite standard therapy, patient survival remains poor. Immune checkpoint blockade targeting the PD-1/PD-L1 axis has shown promise in other cancers, but its role in gliomas remains under investigation. This study evaluates PD-L1 expression in gliomas and its correlation with tumour grade. A total of 50 histologically confirmed glioma cases were studied. Tumours were graded according to WHO 2021 CNS classification, and immunohistochemistry (IHC) was performed using antibodies for IDH, ATRX, TP53, Ki67, and PD-L1. PD-L1 expression was scored using an immunoreactivity scale, and its association with tumour grade was analysed using ordinal regression. A p-value < 0.05 was considered statistically significant. Among the 50 gliomas, the majority were astrocytoma, IDH-mutant (54%) followed by glioblastoma, IDH-wild type (26%). Most tumours were grade 4 (44%), grade 2 (34%), or grade 3 (18%). PD-L1 expression was detected exclusively in grade 4 tumours, with 6 of 22 (27.27%) cases showing positive expression. No expression was noted in grade 1–3 tumours. The association between PD-L1 expression and tumour grade was statistically significant (p=0.007). PD-L1 expression is limited to high-grade (grade 4) gliomas, suggesting a role in immune evasion. These findings support the potential utility of PD-L1 as a biomarker to identify glioma patients who may benefit from anti-PD-1/PD-L1 immunotherapy.
- 2 March 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (3) , 117344
Mycobacterium avium complex presenting as an infected epidermal inclusion cyst of breast: a rare case report
- 2 March 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 115 (3) , 117344
Mycobacterium avium complex presenting as an infected epidermal inclusion cyst of breast: a rare case report
- 16 January 2026
- Published by Elsevier in Revista Española de Patología
- Vol. 59 (1) , 100852
Rare malignant transformation of struma ovarii into follicular thyroid carcinoma: A case report
- 16 January 2026
- Published by Elsevier in Revista Española de Patología
- Vol. 59 (1) , 100852
Rare malignant transformation of struma ovarii into follicular thyroid carcinoma: A case report
- 13 January 2026
- Published by Elsevier in Revista Española de Patología
- Vol. 59 (1) , 100849
Expression of TRIM29 and its association with p40 and TTF1 in lung carcinoma
- 13 January 2026
- Published by Elsevier in Revista Española de Patología
- Vol. 59 (1) , 100849
Expression of TRIM29 and its association with p40 and TTF1 in lung carcinoma
- Open Access
- 24 November 2025
- Published by Georg Thieme Verlag KG in Asian Journal of Neurosurgery
- Vol. 21 (02) , 365-373
Pediatric Neurenteric Cysts of the Spine: A Case Report of Two Cases with Review of Literature
Neurenteric cysts are rare, benign congenital lesions of endodermal origin that primarily affect the spinal cord. Their clinical and radiological presentations can vary significantly, especially in pediatric patients, complicating diagnosis and management. We report two pediatric cases of spinal neurenteric cysts and review the relevant literature. An 11-month-old infant presented with progressive lower limb weakness. Magnetic resonance imaging (MRI) revealed a nonenhancing intradural cystic lesion at the thoracic level. A 14-year-old female reported neck pain and upper limb paresthesia; cervical spine MRI showed a well-demarcated T2-hyperintense cystic lesion. Both patients underwent complete surgical excision. Histopathology confirmed neurenteric cysts, showing pseudostratified or columnar epithelium with interspersed goblet cells. Postoperative recovery was uneventful, with no recurrence at 6-month and 1-year follow-up, respectively. These cases underscore the variability in presentation and spinal level involvement of neurenteric cysts in children. MRI plays a central role in preoperative assessment, though definitive diagnosis relies on histopathology. Complete surgical excision remains the treatment of choice, offering favorable outcomes with low recurrence risk. The age extremes and differing anatomical locations in our cases reflect the broad clinical spectrum seen in pediatric patients. Spinal neurenteric cysts should be considered in children with unexplained spinal cord-related symptoms. Early imaging, accurate histological diagnosis, and total surgical excision are critical for optimal outcomes. Increased clinical awareness and case reporting will aid in improving recognition and management of this rare spinal lesion.
- 24 November 2025
- Published by Georg Thieme Verlag KG in Asian Journal of Neurosurgery
- Vol. 21 (02) , 365-373
Open AccessPediatric Neurenteric Cysts of the Spine: A Case Report of Two Cases with Review of Literature
Neurenteric cysts are rare, benign congenital lesions of endodermal origin that primarily affect the spinal cord. Their clinical and radiological presentations can vary significantly, especially in pediatric patients, complicating diagnosis and management. We report two pediatric cases of spinal neurenteric cysts and review the relevant literature. An 11-month-old infant presented with progressive lower limb weakness. Magnetic resonance imaging (MRI) revealed a nonenhancing intradural cystic lesion at the thoracic level. A 14-year-old female reported neck pain and upper limb paresthesia; cervical spine MRI showed a well-demarcated T2-hyperintense cystic lesion. Both patients underwent complete surgical excision. Histopathology confirmed neurenteric cysts, showing pseudostratified or columnar epithelium with interspersed goblet cells. Postoperative recovery was uneventful, with no recurrence at 6-month and 1-year follow-up, respectively. These cases underscore the variability in presentation and spinal level involvement of neurenteric cysts in children. MRI plays a central role in preoperative assessment, though definitive diagnosis relies on histopathology. Complete surgical excision remains the treatment of choice, offering favorable outcomes with low recurrence risk. The age extremes and differing anatomical locations in our cases reflect the broad clinical spectrum seen in pediatric patients. Spinal neurenteric cysts should be considered in children with unexplained spinal cord-related symptoms. Early imaging, accurate histological diagnosis, and total surgical excision are critical for optimal outcomes. Increased clinical awareness and case reporting will aid in improving recognition and management of this rare spinal lesion.